Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024

レポーター遺伝子アッセイの世界市場予測(~2024年)

◆タイトル:Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024
◆商品コード:BT-6990
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年3月28日
◆ページ数:161
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

レポーター遺伝子アッセイの世界市場は、2018年の推定16億米ドルから2024年には26億米ドルに達し、この期間中10.1%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、細胞ベース研究に対する資金援助増加、遺伝子発現用途の拡大、および細胞ベースのアッセイの選好の高まりが考えられます。一方で、細胞生物学研究の高コストは、市場の成長を抑制すると予想されます。当調査レポートでは、レポーター遺伝子アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、試薬・アッセイキット(ルシフェラーゼ、緑色蛍光タンパク質、β-グルクロニダーゼ、β-ガラクトシダーゼ)分析、用途(遺伝子調節、タンパク質相互作用、細胞シグナル伝達経路)分析、エンドユーザー分析、レポーター遺伝子アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The reporter gene assays market is projected to grow at a CAGR of 10.1%.”The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%. Growth in this market is driven by increasing funding for cell-based research, the growing applications of gene expression, and a rising preference for cell-based assays. However, the high cost of cell biology research is expected to restrain the growth of this market to a certain extent during the forecast period.

By end user, the academic and research institutes segment is projected to have the largest market share during the forecast period (2019–2024).”
On the basis of end user, the reporter gene assays market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and contract research organizations. The academic and research institutes segment is expected to account for the largest share in 2019. The large share of this end-user segment can be attributed to the increasing government initiatives towards drug discovery and life science R&D activities.

“The cell signaling segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. The cell signaling applications segment is expected to witness the highest CAGR owing to its importance in several cellular functionalities such as cell differentiation, cell fate determination, and cell growth, and advanced applications of cell signaling in life science sectors such as biotechnology, molecular biology, and microbiology.

“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global reporter gene assays market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the large population in China and India, rising geriatric population, and increasing incidence of chronic diseases. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.

The breakdown of primary participants was as mentioned below:
• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–45%, Europe–20%, Asia Pacific–30%, and RoW–5%

The prominent players in the global reporter gene assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Promega Corporation (US), Abcam plc (UK), PerkinElmer (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Geno Technology (US), GeneCopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), and Biotium (US).

Research Coverage:
The report analyzes the various reporter gene assays products and their adoption pattern. It aims at estimating the market size and future growth potential of the global reporter gene assays market for different segments such as products, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global reporter gene assays market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global reporter gene assays market
• Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global reporter gene assays market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global reporter gene assays market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 24
2.1.2.2 Break down of primary sources 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 REPORTER GENE ASSAYS: MARKET OVERVIEW 32
4.2 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2018) 33
4.3 REGIONAL MIX: REPORTER GENE ASSAYS MARKET (2019–2024) 34
4.4 REPORTER GENE ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Increasing funding for cell-based research 36
5.2.1.2 Growing applications of gene expression 36
5.2.1.3 Rising preference for cell-based assays 37

5.2.2 RESTRAINT 37
5.2.2.1 High cost of cell biology research 37
5.2.3 OPPORTUNITIES 38
5.2.3.1 Emerging countries 38
5.2.3.2 Increasing demand for personalized medicine 38
6 REPORTER GENE ASSAYS MARKET, BY PRODUCT 40
6.1 INTRODUCTION 41
6.2 ASSAY KITS 42
6.2.1 LUCIFERASE ASSAY KITS 43
6.2.1.1 Luciferase assays dominate the assay kits market 43
6.2.2 FLUORESCENT PROTEIN-RELATED ASSAY KITS 45
6.2.2.1 Fluorescent reporter proteins are useful in studying cellular events 45
6.2.3 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS 46
6.2.3.1 Advantages of SEAP assays over luciferase and CAT counterparts have supported the growth of this segment 46
6.2.4 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS 47
6.2.4.1 A CAT assay is a standard method for assessing promotor expression in transfected cell lines 47
6.2.5 BETA-GALACTOSIDASE ASSAY KITS 48
6.2.5.1 Ease of use and rapidity of these assays have contributed to their overall demand 48
6.2.6 BETA-GLUCURONIDASE ASSAY KITS 49
6.2.6.1 GUS reporter assays are mainly used for plant gene expression research 49
6.2.7 OTHER ASSAY KITS 50
6.3 REAGENTS 51
6.3.1 INCREASING DEMAND FOR HIGH-QUALITY REAGENTS IN BIOSCIENCES AND BIOTECHNOLOGY HAS DRIVEN REAGENT USE 51
7 REPORTER GENE ASSAYS MARKET, BY APPLICATION 52
7.1 INTRODUCTION 53
7.2 CELL SIGNALING PATHWAYS 54
7.2.1 CELL SIGNALING PATHWAYS IS THE LARGEST APPLICATION SEGMENT OF THE REPORTER GENE ASSAYS MARKET 54
7.3 PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS 55
7.3.1 REPORTER GENE ASSAYS ALLOW FOR THE FUNCTIONAL IDENTIFICATION AND CHARACTERIZATION OF PROMOTER AND ENHANCER ELEMENTS 55
7.4 GENE REGULATION 56
7.4.1 REPORTER GENE ASSAYS ACTS AS POWERFUL TOOLS IN ANALYZING GENE REGULATIONS 56
7.5 PROTEIN INTERACTION 58
7.5.1 REPORTER GENE ASSAYS ARE USED FOR THE IDENTIFICATION AND QUANTITATIVE ANALYSIS OF PROTEIN-PROTEIN INTERACTION 58
8 REPORTER GENE ASSAYS MARKET, BY END USER 60
8.1 INTRODUCTION 61
8.2 ACADEMIC & RESEARCH INSTITUTES 62
8.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE REPORTER GENE ASSAYS MARKET 62
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
8.3.1 INCREASING NUMBER OF R&D ACTIVITIES TO DRIVE THE MARKET GROWTH FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 64
8.4.1 CROS TO PROVIDE AFFORDABLE OUTLETS FOR COMPANIES AND ACADEMIA TO PURSUE NEW MEDICINES 64
8.5 HOSPITAL & DIAGNOSTIC LABORATORIES 65
8.5.1 HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES 65
9 REPORTER GENE ASSAYS MARKET, BY REGION 67
9.1 INTRODUCTION 68
9.2 NORTH AMERICA 69
9.2.1 US 73
9.2.1.1 US dominates the North American reporter gene assays market 73
9.2.2 CANADA 76
9.2.2.1 Canada to witness the highest growth in the North American market primarily due to the increasing research activities 76
9.3 EUROPE 79
9.3.1 GERMANY 83
9.3.1.1 Favorable funding scenario to support market growth in Germany 83
9.3.2 FRANCE 86
9.3.2.1 Increasing government investments in proteomics & genomics research to drive market growth 86
9.3.3 UK 88
9.3.3.1 Surge in the prevalence of cancer and neurological disorders is driving the adoption of reporter gene assays 88
9.3.4 ITALY 91
9.3.4.1 Growing proteomics and genomics research to drive the growth of the reporter gene assays market in Italy 91
9.3.5 SPAIN 93
9.3.5.1 Increasing private and public funding for cell-based research and the presence of a strong R&D infrastructure to drive market growth 93
9.3.6 REST OF EUROPE 96

9.4 ASIA PACIFIC 98
9.4.1 CHINA 102
9.4.1.1 China to register the highest growth in the global reporter gene assays market, primarily due to the large R&D investments in the country 102
9.4.2 JAPAN 105
9.4.2.1 Increasing incidence of chronic diseases and growing geriatric population to drive market growth 105
9.4.3 INDIA 107
9.4.3.1 Expansion of pharmaceutical companies 107
9.4.4 REST OF ASIA PACIFIC 109
9.5 LATIN AMERICA 112
9.5.1 INCREASING NUMBER OF PROTEOMICS AND GENOMICS RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH IN THE REGION 112
9.6 MIDDLE EAST & AFRICA 114
9.6.1 SEVERAL LEADING GLOBAL PLAYERS ARE FOCUSING ON EXPANDING THEIR PRESENCE IN THE MEA REGION 114
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 MARKET SHARE ANALYSIS 117
10.2.1 MARKET SHARE ANALYSIS: REPORTER GENE ASSAYS MARKET 117
10.3 COMPETITIVE LEADERSHIP MAPPING 119
10.3.1 VISIONARY LEADERS 119
10.3.2 INNOVATORS 119
10.3.3 DYNAMIC DIFFERENTIATORS 119
10.3.4 EMERGING COMPANIES 120
10.4 COMPETITIVE SITUATION AND TRENDS 121
10.4.1 EXPANSIONS 121
10.4.2 ACQUISITIONS 121
11 COMPANY PROFILES 123
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MERCK KGAA 123
11.2 THERMO FISHER SCIENTIFIC, INC. 127
11.3 PROMEGA CORPORATION 131
11.4 PERKINELMER 133
11.5 ABCAM PLC 136
11.6 BECTON, DICKINSON AND COMPANY 138
11.7 BIO-RAD LABORATORIES 140
11.8 DANAHER CORPORATION 142
11.9 BIOTIUM 144
11.10 PROMOCELL 146
11.11 INVIVOGEN 148
11.12 GENO TECHNOLOGY, INC. 149
11.13 GENECOPOEIA, INC. 150

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 151
12.1 INSIGHTS OF INDUSTRY EXPERTS 151
12.2 DISCUSSION GUIDE 152
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 156
12.4 AVAILABLE CUSTOMIZATIONS 158
12.5 RELATED REPORTS 159
12.6 AUTHOR DETAILS 160

LIST OF TABLES

TABLE 1 REPORTER GENE ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES 35
TABLE 2 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 41
TABLE 3 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 42
TABLE 4 REPORTER GENE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 43
TABLE 5 LUCIFERASE ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 44
TABLE 6 FLUORESCENT PROTEIN-RELATED ASSAY KITS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 45
TABLE 7 SECRETED EMBRYONIC ALKALINE PHOSPHATASE ASSAY KITS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 46
TABLE 8 CHLORAMPHENICOL ACETYLTRANSFERASE ASSAY KITS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 9 BETA-GALACTOSIDASE ASSAY KITS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 48
TABLE 10 BETA-GLUCURONIDASE ASSAY KITS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 49
TABLE 11 OTHER ASSAY KITS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 50
TABLE 12 REPORTER GENE ASSAY REAGENTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 51
TABLE 13 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 53
TABLE 14 REPORTER GENE ASSAYS MARKET FOR CELL SIGNALING PATHWAYS,
BY COUNTRY, 2017–2024 (USD MILLION) 54
TABLE 15 REPORTER GENE ASSAYS MARKET FOR PROMOTER STRUCTURAL AND FUNCTIONAL ANALYSIS, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 16 REPORTER GENE ASSAYS MARKET FOR GENE REGULATION,
BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 17 REPORTER GENE ASSAYS MARKET FOR PROTEIN INTERACTION, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 18 REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 61
TABLE 19 REPORTER GENE ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 20 REPORTER GENE ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION) 64
TABLE 21 REPORTER GENE ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 22 REPORTER GENE ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 23 REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 24 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 71
TABLE 25 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 71
TABLE 26 NORTH AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 72
TABLE 27 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 72
TABLE 28 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 73
TABLE 29 US: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 74
TABLE 30 US: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 31 US: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 75
TABLE 32 US: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 75
TABLE 33 CANADA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 77
TABLE 34 CANADA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 77
TABLE 35 CANADA: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 78
TABLE 36 CANADA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 78
TABLE 37 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 81
TABLE 38 EUROPE: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 81
TABLE 39 EUROPE: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 82
TABLE 40 EUROPE: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 82
TABLE 41 EUROPE: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 83
TABLE 42 GERMANY: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 84
TABLE 43 GERMANY: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 84
TABLE 44 GERMANY: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 85
TABLE 45 GERMANY: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 85
TABLE 46 FRANCE: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 86
TABLE 47 FRANCE: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 87
TABLE 48 FRANCE: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 87
TABLE 49 FRANCE: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 88
TABLE 50 UK: REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 89
TABLE 51 UK: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 52 UK: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 90
TABLE 53 UK: REPORTER GENE ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 54 ITALY: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 91
TABLE 55 ITALY: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 92
TABLE 56 ITALY: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 92
TABLE 57 ITALY: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 93
TABLE 58 SPAIN: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 94
TABLE 59 SPAIN: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 94
TABLE 60 SPAIN: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 95
TABLE 61 SPAIN: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 95
TABLE 62 ROE: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 96
TABLE 63 ROE: REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 64 ROE: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 97
TABLE 65 ROE: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 98
TABLE 66 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 100
TABLE 67 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 100
TABLE 68 ASIA PACIFIC: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 69 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 101
TABLE 70 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 102
TABLE 71 CHINA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 103
TABLE 72 CHINA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 103
TABLE 73 CHINA: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 104
TABLE 74 CHINA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 104
TABLE 75 JAPAN: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 105
TABLE 76 JAPAN: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 106
TABLE 77 JAPAN: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 106
TABLE 78 JAPAN: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 107
TABLE 79 INDIA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 108
TABLE 80 INDIA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 108
TABLE 81 INDIA: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 109
TABLE 82 INDIA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 109
TABLE 83 ROAPAC: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 110
TABLE 84 ROAPAC: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 110
TABLE 85 ROAPAC: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 111
TABLE 86 ROAPAC: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 111
TABLE 87 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 112
TABLE 88 LATIN AMERICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 113
TABLE 89 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 113
TABLE 90 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 114
TABLE 91 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 115
TABLE 92 MIDDLE EAST & AFRICA: REPORTER GENE ASSAY KITS MARKET, BY TYPE,
2017–2024 (USD MILLION) 115
TABLE 93 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 116
TABLE 94 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 116
TABLE 95 EXPANSIONS, 2016–2019 121
TABLE 96 ACQUISITIONS, 2016–2019 122


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 PRIMARY SOURCES 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 24
FIGURE 4 BOTTOM-UP APPROACH 25
FIGURE 5 TOP-DOWN APPROACH 25
FIGURE 6 DATA TRIANGULATION METHODOLOGY 26
FIGURE 7 REPORTER GENE ASSAYS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 28
FIGURE 8 REPORTER GENE ASSAY KITS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 29
FIGURE 9 REPORTER GENE ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 29
FIGURE 10 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 30
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE REPORTER GENE ASSAYS MARKET 31
FIGURE 12 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 32
FIGURE 13 THE US DOMINATED THE REPORTER GENE ASSAYS MARKET IN 2018 33
FIGURE 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2019–2024) 34
FIGURE 15 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 34
FIGURE 16 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: REPORTER GENE ASSAYS MARKET 35
FIGURE 17 ASSAY KITS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET,
BY PRODUCT, DURING THE FORECAST PERIOD 41
FIGURE 18 CELL SIGNALING PATHWAYS SEGMENT TO DOMINATE THE REPORTER GENE ASSAYS MARKET DURING THE FORECAST PERIOD 53
FIGURE 19 REPORTER GENE ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 61
FIGURE 20 REPORTER GENE ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
FIGURE 21 NORTH AMERICA: REPORTER GENE ASSAYS MARKET SNAPSHOT 70
FIGURE 22 EUROPE: REPORTER GENE ASSAYS MARKET SNAPSHOT 80
FIGURE 23 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET SNAPSHOT 99
FIGURE 24 REPORTER GENE ASSAY MARKET, BY KEY PLAYER, 2018 117
FIGURE 25 REPORTER GENE ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018) 120
FIGURE 26 MERCK KGAA: COMPANY SNAPSHOT 124
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 127
FIGURE 28 PERKINELMER: COMPANY SNAPSHOT 133
FIGURE 29 ABCAM PLC: COMPANY SNAPSHOT 136
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 138
FIGURE 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 140
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT 142


★調査レポート[レポーター遺伝子アッセイの世界市場予測(~2024年)] ( Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024 / BT-6990) 販売に関する免責事項
[レポーター遺伝子アッセイの世界市場予測(~2024年)] ( Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024 / BT-6990) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆